While SSRI antidepressants can help in offering relief from symptoms, in comparison, psilocybin or magic mushrooms might be ...

As a priority of the FY 2025 President’s budget, the Biden-Harris Administration has called for requiring and funding mental ...

Cybin (NYSE American: CYBN) (Cboe CA: CYBN) , a clinical-stage biopharmaceutical company developing new and innovative next-generation psychedelic- ...

A new study compared psilocybin — the active compound in magic mushrooms, with a common antidepressant medication. During 6 ...

Here’s a look at the best and worst states in each of the four data categories: mental health provider ratio, suicide rate ...

A new study has found that psilocybin may be more effective than the antidepressant escitalopram (an SSRI) in treating ...

STIM recently announced that additional payors have updated the coverage of TMS (transcranial magnetic stimulation). This upgrade is aimed at reducing the access barriers for patients with major ...

Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the ...

Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) ...

The first long-term comparison of psilocybin vs an SSRI for MDD suggests the psychedelic was associated with better overall ...

RIM-TD open-label extension (OLE) study showed long-term improvement of Tardive Dyskinesia (TD) symptoms from treatment with deutetrabenazine ...